STANFORD UNIVERSITY
Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases
Targeting bacterial proteases involved in PAR signaling to treat inflammatory bowel diseases is a funding opportunity from STANFORD UNIVERSITY, up to 455063, closing July 31, 2026.
Jul 31, 2026
(0d left)Overview
Project Summary Crohn’s disease and ulcerative colitis are forms of inflammatory bowel disease (IBD) that affect more than 6.8 million patients worldwide. Because no cure is available to date, treatment is limited to reducing IBD symptoms such as severe diarrhea, weight loss, fatigue and pain. Although the exact…